The interrelationship between obesity and race in breast cancer prognosis: a prospective cohort study

被引:1
作者
Schindler, Emma A. [1 ]
Takita, Cristiane [2 ,3 ]
Collado-Mesa, Fernando [4 ]
Reis, Isildinha M. [1 ,2 ]
Zhao, Wei [2 ]
Yang, George R. [1 ]
Acosta, Laura G. [1 ]
Hu, Jennifer J. [1 ,2 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, 1120 NW 14th St,CRB 1511, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
[3] Univ Miami, Miller Sch Med, Dept Radiat Oncol, Miami, FL 33136 USA
[4] Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33136 USA
基金
美国国家卫生研究院;
关键词
Breast cancer; Race/ethnicity; Obesity; Tumor stage; Prognosis; BODY-MASS INDEX; METAANALYSIS; ASSOCIATION; SURVIVAL; OUTCOMES; WOMEN;
D O I
10.1186/s12905-024-03020-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Obesity is associated with an increased breast cancer risk in postmenopausal women and may contribute to worse outcomes. Black women experience higher obesity and breast cancer mortality rates than non-Black women. We examined associations between race, obesity, and clinical tumor stage with breast cancer prognosis.Methods We conducted a prospective cohort study in 1,110 breast cancer patients, using univariable and multivariable Cox regression analyses to evaluate the effects of obesity, race/ethnicity, and clinical tumor stage on progression-free and overall survival (PFS and OS).Results 22% of participants were Black, 64% were Hispanic White, and 14% were non-Hispanic White or another race. 39% of participants were obese (body mass index [BMI] >= 30 kg/m2). In univariable analyses, tumor stage III-IV was associated with worse PFS and OS compared to tumor stage 0-II (hazard ratio [HR] = 4.68, 95% confidence interval [CI] = 3.52-6.22 for PFS and HR = 5.92, 95% CI = 4.00-8.77 for OS). Multivariable analysis revealed an association between Black race and worse PFS in obese (HR = 2.19, 95% CI = 1.06-4.51) and non-obese (HR = 2.11, 95% CI = 1.05-4.21) women with tumors staged 0-II. Obesity alone was not associated with worse PFS or OS.Conclusions Results suggest a complex interrelationship between obesity and race in breast cancer prognosis. The association between the Black race and worse PFS in tumor stages 0-II underscores the importance of early intervention in this group. Future studies are warranted to evaluate whether alternative measures of body composition and biomarkers are better prognostic indicators than BMI among Black breast cancer survivors.
引用
收藏
页数:11
相关论文
共 35 条
  • [21] mTOR pathway gene expression in association with race and clinicopathological characteristics in Black and White breast cancer patients
    Ilozumba, Mmadili N.
    Yao, Song
    Llanos, Adana A. M.
    Omilian, Angela R.
    Zhang, Weizhou
    Datta, Susmita
    Hong, Chi-Chen
    Davis, Warren
    Khoury, Thaer
    Bandera, Elisa, V
    Higgins, Michael
    Ambrosone, Christine B.
    Cheng, Ting-Yuan David
    [J]. DISCOVER ONCOLOGY, 2022, 13 (01)
  • [22] The Impact of Obesity on Breast Cancer Diagnosis and Treatment
    Lee, Kyuwan
    Kruper, Laura
    Dieli-Conwright, Christina M.
    Mortimer, Joanne E.
    [J]. CURRENT ONCOLOGY REPORTS, 2019, 21 (05)
  • [23] The Obesity Paradox in Cancer: a Review
    Lennon, Hannah
    Sperrin, Matthew
    Badrick, Ellena
    Renehan, Andrew G.
    [J]. CURRENT ONCOLOGY REPORTS, 2016, 18 (09)
  • [24] Is obesity an independent prognosis factor in woman breast cancer?
    Majed, Bilal
    Moreau, Thierry
    Senouci, Kamel
    Salmon, Remi J.
    Fourquet, Alain
    Asselain, Bernard
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 111 (02) : 329 - 342
  • [25] DNA methylation modifies the association between obesity and survival after breast cancer diagnosis
    McCullough, Lauren E.
    Chen, Jia
    Cho, Yoon Hee
    Khankari, Nikhil K.
    Bradshaw, Patrick T.
    White, Alexandra J.
    Garbowski, Gail
    Teitelbaum, Susan L.
    Terry, Mary Beth
    Neugut, Alfred I.
    Hibshoosh, Hanina
    Santella, Regina M.
    Gammon, Marilie D.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (01) : 183 - 194
  • [26] Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
    McQuade, Jennifer L.
    Daniel, Carrie R.
    Hess, Kenneth R.
    Mak, Carmen
    Wang, Daniel Y.
    Rai, Rajat R.
    Park, John J.
    Haydu, Lauren E.
    Spencer, Christine
    Wongchenko, Matthew
    Lane, Stephen
    Lee, Dung-Yang
    Kaper, Mathilde
    McKean, Meredith
    Beckermann, Kathryn E.
    Rubinstein, Samuel M.
    Rooney, Isabelle
    Musib, Luna
    Budha, Nageshwar
    Hsu, Jessie
    Nowicki, Theodore S.
    Avila, Alexandre
    Haas, Tomas
    Puligandla, Maneka
    Lee, Sandra
    Fang, Shenying
    Wargo, Jennifer A.
    Gershenwald, Jeffrey E.
    Lee, Jeffrey E.
    Hwu, Patrick
    Chapman, Paul B.
    Sosman, Jeffrey A.
    Schadendorf, Dirk
    Grob, Jean-Jacques
    Flaherty, Keith T.
    Walker, Dana
    Yan, Yibing
    McKenna, Edward
    Legos, Jeffrey J.
    Carlino, Matteo S.
    Ribas, Antoni
    Kirkwood, John M.
    Long, Georgina V.
    Johnson, Douglas B.
    Menzies, Alexander M.
    Davies, Michael A.
    [J]. LANCET ONCOLOGY, 2018, 19 (03) : 310 - 322
  • [27] The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data
    Modi, Natansh D.
    Tan, Jin Quan Eugene
    Rowland, Andrew
    Koczwara, Bogda
    Abuhelwa, Ahmad Y.
    Kichenadasse, Ganessan
    McKinnon, Ross A.
    Wiese, Michael D.
    Sorich, Michael J.
    Hopkins, Ashley M.
    [J]. NPJ BREAST CANCER, 2021, 7 (01)
  • [28] Genetic predisposition to obesity and inflammation in a tri-racial/ethnic breast cancer population
    Puyana, Carolina
    Schindler, Emma
    Lee, Eunkyung
    Hu, Jennifer J.
    [J]. JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS, 2022, 6 (02) : 223 - 239
  • [29] Differentially Expressed Transcripts and Dysregulated Signaling Pathways and Networks in African American Breast Cancer
    Stewart, Paul A.
    Luks, Jennifer
    Roycik, Mark D.
    Sang, Qing-Xiang Amy
    Zhang, Jinfeng
    [J]. PLOS ONE, 2013, 8 (12):
  • [30] Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer
    Vallega, Karin A.
    Liu, NingNing
    Myers, Jennifer S.
    Yu, Kaixian
    Sang, Qing-Xiang Amy
    [J]. PLOS ONE, 2016, 11 (06):